JAK2 and cancer: A recent study suggested that the knockout of genes in the IFN γ receptor signal pathway (IFNGR1, JAK1, or JAK2) endowed solid tumor cells with resistance to CAR-T cells by reducing the overall binding time and affinity of CAR-T cells with the cancer cells [29].